⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Celldex Therapeutics, Inc

$38.09
-0.16 (-0.41%)

Volume:

263.311K ($10.03M)

Market Capitalization:

$2.99B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Celldex Therapeutics, Market Segments

Regular Trading Hours

-3.54(-8.49%)
Open$41.62
Close$38.09
Low$37.48
Low Change-4.14 (-9.95%)
High$41.62
High Change+0.00 (+0.00%)
Range$4.14
Volume263.211K
Dollar Volume$10.02M

Premarket

+0.00(+0.00%)
Open$38.95
Close$38.95
Low$38.95
Low Change0.00 (0.00%)
High$38.95
High Change+0.00 (+0.00%)
Range$0.00
Volume100
Dollar Volume$3.90K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$38.24
Close$38.24
Low$38.24
Low Change0.00 (0.00%)
High$38.24
High Change+0.00 (+0.00%)
Range$0.00
Volume1.228M
Dollar Volume$46.97M

Regular Trading Hours Yesterday

-0.63(-1.62%)
Open$38.87
Close$38.24
Low$37.54
Low Change-1.34 (-3.43%)
High$38.87
High Change+0.00 (+0.00%)
Range$1.34
Volume792.343K
Dollar Volume$30.30M

Premarket Yesterday

-0.07(-0.18%)
Open$38.97
Close$38.90
Low$38.75
Low Change-0.22 (-0.56%)
High$39.20
High Change+0.23 (+0.59%)
Range$0.45
Volume12.503K
Dollar Volume$486.37K

Celldex Therapeutics, Top Trades

Celldex Therapeutics,'s top trade so far today returned +6.85%, while the top short trade returned -9.95%.

Celldex Therapeutics, Moving Averages

5 Day Moving Average (SMA5)$38.73
10 Day Moving Average (SMA10)$38.61
20 Day Moving Average (SMA20)$39.30
50 Day Moving Average (SMA50)$39.12
100 Day Moving Average (SMA100)$35.95
200 Day Moving Average (SMA200)$32.12

Celldex Therapeutics, Statistics

Average Volume (30 Days)779.45K
P/E Ratio (Current)-10.18
EPS (Current)-$3.83
Dividend Yield0.00%
Free Cash Flow-$242.11M
Cash Ratio0.77
Current Ratio11.82
Quick Ratio11.82
Debt to Equity0.00
Enterprise Value$3.01B
EV to EBITDA-9.35
EV to Sales19073.59
Price to Book4.28
Price to Cash Flow
Price to Free Cash Flow
Price to Sales19373.93
Return on Assets-0.38%
Return on Equity-0.42%

Celldex Therapeutics, Stock Splits

There have been 2 stock splits for Celldex Therapeutics, (CLDX). The last reverse stock split occured on February 11, 2019 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Feb 11, 2019Reverse15:1
Mar 7, 2008Reverse12:1

Celldex Therapeutics, Dividends

There have been no dividends for Celldex Therapeutics, (CLDX).